73 research outputs found
Safety survey data from Victorian youth-serving organisations: Survey data from workers, young people, and organisational leaders’ self-reflections after implementing the Victorian Child Safe Standards
In 2015, the Victorian Government Department of Health and Human Services (DHHS) introduced the Victorian Child Safe Standards (the Standards). The aim was to promote the safety of children and young people by supporting the way in which organisations, their workforce (staff and volunteers) and members work so that protecting children and young people is always considered, taken seriously and acted upon. These Standards became fully operational in 2017. In 2019 DHHS began a review of the extent to which the Standards promote improvements in the child-safe culture, and the extent to which the regulatory scheme supports compliance by organisations.
As part of the review, DHHS commissioned the Australian Catholic University’s Institute of Child Protection Studies (ICPS) to undertake surveys of staff, children, young people and leaders in a variety of youth-serving organisations. This report describes each survey in detail, presents an analysis of the participants, and describes the methodology. We It also presents our findings, addressing each standard individually, with a summary of overall findings related to the Standards as an overall regulatory framework for driving a culture of child-safety within all youth serving organisations across Victoria
Effective interventions to reduce suicidal thoughts and behaviours among children in contact with child protection and out-of-home care systems – A rapid evidence review
[Extract]
Aim
The aim of this rapid evidence review is to outline the role played by involvement in the child protection system—including placement in OOHC—as a risk factor for suicidal behaviour. We also aim to review the effectiveness of interventions focused on OOHC for at-risk children in reducing suicidal thoughts, suicide attempts and suicide deaths.
The National Suicide Prevention Taskforce, through the Suicide Prevention Research Fund managed by Suicide Prevention Australia, commissioned the Institute of Child Protection Studies at Australian Catholic University to conduct this review of the literature. We aimed to answer the following research questions:
1. What role do risk factors associated with childhood trauma and interactions with the child protection and out-of-home system play in suicidal behaviour?
2. What interventions have been shown to be effective in reducing suicidal thoughts and behaviours among children involved in the out-of-home care system?
3. What recommendations could be made about interventions that may be most appropriate and feasible within the Australian context
Sociodemographic disparities in survival from colorectal cancer in South Australia: a population-wide data linkage study
Copyright © Beckmann et al. 2016
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Background: Inequalities in survival from colorectal cancer (CRC) across socioeconomic groups and by area of
residence have been described in various health care settings. Few population-wide datasets which include
clinical and treatment information are available in Australia to investigate disparities. This study examines
socio-demographic differences in survival for CRC patients in South Australia (SA), using a population-wide
database derived via linkage of administrative and surveillance datasets.
Methods: The study population comprised all cases of CRC diagnosed in 2003-2008 among SA residents
aged 50-79 yrs in the SA Central Cancer Registry. Measures of socioeconomic status (area level), geographical
remoteness, clinical characteristics, comorbid conditions, treatments and outcomes were derived through record
linkage of central cancer registry, hospital-based clinical registries, hospital separations, and radiotherapy services data
sources. Socio-demographic disparities in CRC survival were examined using competing risk regression analysis.
Results: Four thousand six hundred and forty one eligible cases were followed for an average of 4.7 yrs, during which
time 1525 died from CRC and 416 died from other causes. Results of competing risk regression indicated higher risk of
CRC death with higher grade (HR high v low =2.25, 95 % CI 1.32-3.84), later stage (HR C v A = 7.74, 95 % CI 5.75-10.4),
severe comorbidity (HR severe v none =1.21, 95 % CI 1.02-1.44) and receiving radiotherapy (HR = 1.41, 95 % CI 1.18-1.68).
Patients from the most socioeconomically advantaged areas had significantly better outcomes than those from the least
advantaged areas (HR =0.75, 95 % 0.62-0.91). Patients residing in remote locations had significantly worse outcomes than
metropolitan residents, though this was only evident for stages A-C (HR = 1.35, 95 % CI 1.01-1.80). These disparities were
not explained by differences in stage at diagnosis between socioeconomic groups or area of residence. Nor were they
explained by differences in patient factors, other tumour characteristics, comorbidity, or treatment modalities.
Conclusions: Socio-economic and regional disparities in survival following CRC are evident in SA, despite having
a universal health care system. Of particular concern is the poorer survival for patients from remote areas with
potentially curable CRC. Reasons for thes
Health-related quality of life (HRQoL) in sarcoidosis:Diagnosis, management and health outcomes
A large scale hearing loss screen reveals an extensive unexplored genetic landscape for auditory dysfunction
The developmental and physiological complexity of the auditory system is likely reflected in the underlying set of genes involved in auditory function. In humans, over 150 non-syndromic loci have been identified, and there are more than 400 human genetic syndromes with a hearing loss component. Over 100 non-syndromic hearing loss genes have been identified in mouse and human, but we remain ignorant of the full extent of the genetic landscape involved in auditory dysfunction. As part of the International Mouse Phenotyping Consortium, we undertook a hearing loss screen in a cohort of 3006 mouse knockout strains. In total, we identify 67 candidate hearing loss genes. We detect known hearing loss genes, but the vast majority, 52, of the candidate genes were novel. Our analysis reveals a large and unexplored genetic landscape involved with auditory function
Recommended from our members
Comparisons of the factor structure and measurement invariance of the Spence children’s anxiety scale - parent version in children with autism spectrum disorder and typically developing anxious children
The Spence Children’s Anxiety Scale - Parent version (SCAS-P) is often used to assess anxiety in children with autism spectrum disorder (ASD), however, little is known about the validity of the tool in this population. The aim of this study was to determine whether the SCAS-P has the same factorial validity in a sample of young people with ASD (n=285), compared to a sample of typically developing young people with anxiety disorders (n=224). Poor model fit with all of the six hypothesised models precluded invariance testing. Exploratory factor analysis indicated that different anxiety phenomenology characterises the two samples. The findings suggest that cross-group comparisons between ASD and anxious samples based on the SCAS-P scores may not always be appropriat
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
The early detection of relapse following primary surgery for non-small-cell lung cancer and the characterization of emerging subclones, which seed metastatic sites, might offer new therapeutic approaches for limiting tumour recurrence. The ability to track the evolutionary dynamics of early-stage lung cancer non-invasively in circulating tumour DNA (ctDNA) has not yet been demonstrated. Here we use a tumour-specific phylogenetic approach to profile the ctDNA of the first 100 TRACERx (Tracking Non-Small-Cell Lung Cancer Evolution Through Therapy (Rx)) study participants, including one patient who was also recruited to the PEACE (Posthumous Evaluation of Advanced Cancer Environment) post-mortem study. We identify independent predictors of ctDNA release and analyse the tumour-volume detection limit. Through blinded profiling of postoperative plasma, we observe evidence of adjuvant chemotherapy resistance and identify patients who are very likely to experience recurrence of their lung cancer. Finally, we show that phylogenetic ctDNA profiling tracks the subclonal nature of lung cancer relapse and metastasis, providing a new approach for ctDNA-driven therapeutic studies
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Immune evasion is a hallmark of cancer. Losing the ability to present neoantigens through human leukocyte antigen (HLA) loss may facilitate immune evasion. However, the polymorphic nature of the locus has precluded accurate HLA copy-number analysis. Here, we present loss of heterozygosity in human leukocyte antigen (LOHHLA), a computational tool to determine HLA allele-specific copy number from sequencing data. Using LOHHLA, we find that HLA LOH occurs in 40% of non-small-cell lung cancers (NSCLCs) and is associated with a high subclonal neoantigen burden, APOBEC-mediated mutagenesis, upregulation of cytolytic activity, and PD-L1 positivity. The focal nature of HLA LOH alterations, their subclonal frequencies, enrichment in metastatic sites, and occurrence as parallel events suggests that HLA LOH is an immune escape mechanism that is subject to strong microenvironmental selection pressures later in tumor evolution. Characterizing HLA LOH with LOHHLA refines neoantigen prediction and may have implications for our understanding of resistance mechanisms and immunotherapeutic approaches targeting neoantigens. Video Abstract [Figure presented] Development of the bioinformatics tool LOHHLA allows precise measurement of allele-specific HLA copy number, improves the accuracy in neoantigen prediction, and uncovers insights into how immune escape contributes to tumor evolution in non-small-cell lung cancer
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
CD25 is expressed at high levels on regulatory T (Treg) cells and was initially proposed as a target for cancer immunotherapy. However, anti-CD25 antibodies have displayed limited activity against established tumors. We demonstrated that CD25 expression is largely restricted to tumor-infiltrating Treg cells in mice and humans. While existing anti-CD25 antibodies were observed to deplete Treg cells in the periphery, upregulation of the inhibitory Fc gamma receptor (FcγR) IIb at the tumor site prevented intra-tumoral Treg cell depletion, which may underlie the lack of anti-tumor activity previously observed in pre-clinical models. Use of an anti-CD25 antibody with enhanced binding to activating FcγRs led to effective depletion of tumor-infiltrating Treg cells, increased effector to Treg cell ratios, and improved control of established tumors. Combination with anti-programmed cell death protein-1 antibodies promoted complete tumor rejection, demonstrating the relevance of CD25 as a therapeutic target and promising substrate for future combination approaches in immune-oncology
- …